Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

5794 - Safety and Outcomes of Self-expandable Metal Stents (SEMS) versus Emergency Surgery for Acute Colonic Obstruction in Metastatic Colon Cancer patients treated with Bevacizumab (BV)

Date

21 Oct 2018

Session

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

Topics

Surgical Oncology

Tumour Site

Colon and Rectal Cancer

Presenters

Vilma Pacheco-Barcia

Citation

Annals of Oncology (2018) 29 (suppl_8): viii150-viii204. 10.1093/annonc/mdy281

Authors

V.E. Pacheco-Barcia1, R. Mondéjar Solís2, O. Martínez-Sáez3, F. Longo4, E. Bermejo5, J.A. Moreno6, C. Marin5, A. Correa5, R. maqueda5, J. Rogado7, A. García de Paredes8, E. Rodriguez de Santiago8, V. Pachón Olmos3, R. Ferreiro Monteagudo3, M. Rodriguez Garrote3, A. Carrato Mena4, O. Donnay1, E. Martin Perez5, C. Santander6, R. Colomer Bosch7

Author affiliations

  • 1 Medical Oncology. Instituto De Investigación Sanitaria La Princesa, Hospital Universitario de La Princesa, 28006 - Madrid/ES
  • 2 Medical Oncology, Hospital Universitario de La Princesa, 28006 - Madrid/ES
  • 3 Medical Oncology, Hospital Universitario Ramón y Cajal, 28034 - Madrid/ES
  • 4 Medical Oncology, Hospital Universitario Ramon y Cajal, 28031 - Madrid/ES
  • 5 Surgical oncology, Hospital Universitario La Princesa, 28006 - Madrid/ES
  • 6 Gastroenterology, Hospital Universitario de La Princesa, 28006 - Madrid/ES
  • 7 Medical Oncology. Instituto De Investigación Sanitaria La Princesa. Instituto De Investigación Sanitaria La Princesa, Hospital Universitario de La Princesa, 28006 - Madrid/ES
  • 8 Gastroenterology, Hospital Universitario Ramon y Cajal, 28031 - Madrid/ES

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 5794

Background

Colorectal cancer presents with malignant bowel obstruction in about 10% of cases. SEMS can be an alternative for immediate surgery but long-term data is limited regarding clinical outcomes and safety of BV in this subset of patients.

Methods

We performed a retrospective review of 2850 cases of colon cancer from January 2012 to October 2017, and identified metastatic patients with malignant bowel obstruction initially treated with SEMS or emergency surgery. Differences in procedure-related morbidity and overall survival (OS) were assessed.

Results

We selected 119 cases, 79 treated with SEMS and 40 with surgery. Median age: 76. Median follow-up time: 11 months. No differences in sidedness or RAS status between cohorts. SEMS and surgery had a similar rate of complications (35.5% vs 32.5%, p = 0.45) and showed longer time to complications (18m vs 1m, p = 0.004). In patients treated with BV, complications were similar in SEMS and surgery (40% vs 31%, RR 1.28, p = 0.5) and perforation was also similar (13% vs 19%, RR 1.46, p = 0.4). The incidence of perforation in the SEMS group was similar between BV and chemotherapy alone (13% vs 9%, p = 0.2). In patients without systemic therapy, complications were higher in the surgery group compared to SEMS (50% vs 25%, RR 1.34, p = 0.1), also the incidence of perforation (20% vs 6%, RR 1.57, p = 0.2), but not statistically significant. SEMS and surgery showed similar OS (14m vs 15m, p = 0.5). Treatment with BV increased OS in SEMS group (18 months vs 7 months, p = 0.001) and surgery group (20 months vs 4 months, p = 0.001) compared to patients without subsequent medical treatment. In the multivariate analysis, patients treated with subsequent medical treatment showed a statistically significant longer OS [HR 0.43, CI95% 0.19-0.94, p = 0.02] and patients who had complications, showed a shorter OS (HR 2.45, CI95% 1.17-5.12, p = 0.01).

Conclusions

Bevacizumab-based therapy increased survival in metastatic colon cancer and, was not associated with a higher risk of perforation in patients with SEMS. Emergency surgery and SEMS showed a similar incidence of complications and perforations, with no differences between both strategies in patients treated with BV.

Clinical trial identification

Legal entity responsible for the study

Hospital Universitario La Princesa, Instituto de Investigación Sanitaria La Princesa.

Funding

Has not received any funding.

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.